Search Results 811-820 of 24225 for B cell lymphomas
It has shown great promise by putting some B-cell lymphomas and leukemias into remission. CAR-T cells are highly targeted to tumor cells, with the goal of ...
Related. Basal cell carcinoma · B-cell lymphoma · Burkitt lymphoma · Cancer · Carcinoid syndrome · Chronic myelogenous leukemia · Diffuse large B-cell lymphoma ...
Follicular lymphoma and diffuse large B-cell lymphoma with BCL2 and IRF4 rearrangements in adult patients. Hum Pathol. 2023 Nov; 141:22-29 Epub 2023 Aug 25
DEAR MAYO CLINIC: My father just started chemotherapy for lymphoma, and he is scheduled for a positron emission tomography or PET scan after his first three ...
Giving rituximab together with romidepsin and lenalidomide may be a better treatment for B-cell non-Hodgkin lymphoma. A Study to Compare Somatostatin Analogues ...
... B-cell lymphoid malignancies. Participation eligibility. Participant ... lymphoma/leukemia, plasma cell myeloma, acute lymphoblastic leukemia, lymphoblastic ...
... B-cell lymphoma 2 (BCL2) inhibitor. A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma.
... lymphoma. CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/Refractory B Cell Malignancies. Rochester, Minn. The purpose of this study is to ...
The purpose of this study is to provide access to CTL019 through Managed Access Program (MAP) for acute lymphoblastic leukemia (ALL) or diffuse large b-cell ...
... Cell Lung Cancer. MC230818 Understanding the mechanisms of clonal and ... B-cell lymphoma 2 (BCL2) inhibitor. A Novel Vaccine (EO2463) as Monotherapy ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!